2009
DOI: 10.1158/0008-5472.can-09-0420
|View full text |Cite
|
Sign up to set email alerts
|

Cytogenetic and cDNA Microarray Expression Analysis of MCF10 Human Breast Cancer Progression Cell Lines

Abstract: We used a combination of spectral karyotyping, array comparative genomic hybridization, and cDNA microarrays to gain insights into the structural and functional changes of the genome in the MCF10 human breast cancer progression model cell lines. Spectral karyotyping data showed several chromosomal aberrations and array comparative genomic hybridization analysis identified numerous genomic gains and losses that might be involved in the progression toward cancer. Analysis of the expression levels of genes locate… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
42
2

Year Published

2009
2009
2016
2016

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(46 citation statements)
references
References 44 publications
2
42
2
Order By: Relevance
“…Moreover, we identified large blocks of inter-chromosomal interactions between Chr 3 and Chr 5, Chr 3 and Chr 9, and Chr 6 and Chr 19, which represent previously known translocations in the MCF-10A genome (Supplemental Fig. S5; Marella et al 2009;Barutcu et al 2015). Taken together, these analyses reflect the high quality and reproducibility of the Hi-C data.…”
Section: Hi-c Analysis Of Smarca4 Knockdown and Control Mcf-10a Cellssupporting
confidence: 62%
“…Moreover, we identified large blocks of inter-chromosomal interactions between Chr 3 and Chr 5, Chr 3 and Chr 9, and Chr 6 and Chr 19, which represent previously known translocations in the MCF-10A genome (Supplemental Fig. S5; Marella et al 2009;Barutcu et al 2015). Taken together, these analyses reflect the high quality and reproducibility of the Hi-C data.…”
Section: Hi-c Analysis Of Smarca4 Knockdown and Control Mcf-10a Cellssupporting
confidence: 62%
“…Besides being frequently used in in vitro transformation assays MCF10A cell line was used for comprehensive analysis of the MCF10A series of cell lines representing progression towards recognizable malignancy [8], [9]. The MCF10A progression model consists of three directly derived cell lines: the spontaneously immortalized MCF10A cells (do not show any characteristics of invasiveness or tumor formation), MCF10AT1 cells (MCF10A cells transformed by HRAS), and MCF10CA1a cells (obtained from MCF10AT1 cells after xenograft transplantation in immune-deficient mice [8], [9]. Each of these cell lines showed specific quantitative chromosomal changes in addition to carrying a few common changes seen in all cell lines [13], [14].…”
Section: Functional Cell Line Groupingmentioning
confidence: 99%
“…Each of these cell lines showed specific quantitative chromosomal changes in addition to carrying a few common changes seen in all cell lines [13], [14]. Spectral karyotyping analysis showed that qualitative changes for example premalignant MCF10AT1 gained additional translocations to the MCF10A, whereas the malignant MCF10CA1a had more translocations than both MCF10A and MCF10AT1 [8]. Array comparative genome hybridization (aCGH) showed that MCF10A had a number of gains and losses of different chromosome regions and progression towards full malignancy was accompanied by much more widespread genomic aberrations.…”
Section: Functional Cell Line Groupingmentioning
confidence: 99%
See 1 more Smart Citation
“…Our previous report demonstrated that expression of the LIF gene was upregulated during breast cancer progression in the isogenic MCF10 model (Rhee et al, 2008). The isogenic MCF10 human breast cancer model, which includes seven different cell lines originally derived from the same parent cell line, provides an opportunity to study breast cancer initiation, development, and progression (Hurst et al, 2009;Marella et al, 2009;Rhee et al, 2008;Santner et al, 2001;Worsham et al, 2006). In this study, we tested if increased expression of the LIF gene during progression to breast cancer could be correlated with changes in the DNA methylation pattern of its promoter region.…”
Section: Introductionmentioning
confidence: 99%